Pharmaceutical Materials

Iglitazone free base, with a CAS number of 761423-87-4, is actually a misnomer as the correct compound associated with this CAS number is Ipragliflozin, not Iglitazone. Ipragliflozin is a highly selective sodium-glucose cotransporter 2 (SGLT2) inhibitor, used primarily in the treatment of type 2 diabetes.

It works by inhibiting the reabsorption of glucose in the kidney, thereby promoting glucose excretion and lowering blood glucose levels. Ipragliflozin has been shown to be effective and well-tolerated in patients with type 2 diabetes, particularly those who are receiving insulin therapy. Despite the naming confusion, Ipragliflozin (CAS 761423-87-4) remains an important therapeutic option for managing blood glucose levels in diabetic patients.

Name	Ipragliflozin (Correct Compound for CAS 761423-87-4)
CAS Number	761423-87-4
Molecular Formula	C21H21FO5S
Molecular Weight	404.45 g/mol
Appearance	White to off-white powder
Purity	Typically 98%-99%
Applications	Sodium-glucose cotransporter 2 (SGLT2) inhibitor, used in the treatment of type 2 diabetes.
Storage Conditions	Store in a cool, dry place away from light and moisture.
Safety Information	Handle with appropriate personal protective equipment. Refer to the safety data sheet for detailed information.

,Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.

If you're ready to take the next step, Leave your message below and we’ll reply soon. 20+ years of chemical manufacturing & export experience, a partner you can trust.